R Marshall Austin
Overview
Explore the profile of R Marshall Austin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
104
Citations
478
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Farchoukh L, Onisko A, Austin R
J Pathol Inform
. 2020 Jun;
11:9.
PMID: 32477615
Background: Cervical screening could potentially be improved by better stratifying individual risk for the development of cervical cancer or precancer, possibly even allowing follow-up of individual patients differently than proposed...
12.
13.
Cox B, Fitzgerald P, Austin R, Sneyd M
J Am Soc Cytopathol
. 2019 Sep;
8(5):258-264.
PMID: 31543225
Introduction: Our objective was to evaluate the impact on the incidence of cervical cancer in New Zealand of 5-yearly human papillomavirus (HPV) primary screening compared with 3-yearly cytology. Materials And...
14.
Tao X, Austin R, Kong L, Sun Q, Lv Q, Xu H, et al.
J Am Soc Cytopathol
. 2019 Sep;
8(5):250-257.
PMID: 31543224
Introduction: Cervical cancer rates in China remain high, with only limited opportunistic screening in urban centers and large mostly unscreened rural areas. Cervical cytology practices in China have been changing...
15.
Perkins R, Austin R, Zhao C, Saslow D, Massad L
J Low Genit Tract Dis
. 2019 May;
23(3):205-209.
PMID: 31135652
No abstract available.
16.
Woodard A, Austin R, Li Z, Beere J, Zhao C
J Am Soc Cytopathol
. 2019 May;
4(5):261-266.
PMID: 31051763
Introduction: Management of human papillomavirus (HPV)-positive/cytology-negative patients has represented a special challenge ever since the introduction in 2003 of routine cytology and HPV cotesting of women 30 years and older....
17.
Zhao C, Hong W, Li Z, Weng B, Amin M, Austin R
J Am Soc Cytopathol
. 2019 May;
3(1):15-20.
PMID: 31051725
Introduction: Recently published guidelines now specifically recommend cytology and HPV cotesting as follow-up after high-grade cervical intraepithelial neoplasia (CIN 2/3) excision. Materials And Methods: A total of 988 patients with...
18.
Zheng B, Austin R, Liang X, Li Z, Chen C, Yan S, et al.
J Am Soc Cytopathol
. 2019 May;
4(2):84-89.
PMID: 31051714
Introduction: Cervical cancer remains a major health problem in China, where no uniform national standards for cervical cytology quality control exist. This study extends previously reported findings on cervical cytology...
19.
Davey D, Austin R, Birdsong G, Zaleski S
J Am Soc Cytopathol
. 2019 May;
3(4):188-198.
PMID: 31051685
The Clinical Laboratory Improvement Amendments of 1988 were passed into law on October 31, 1988; regulations implementing this law have had a dramatic impact on the practice of cytology as...
20.
Austin R, Herbert A
J Am Soc Cytopathol
. 2019 May;
7(6):289-291.
PMID: 31043297
No abstract available.